Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Bronstein, Gewirtz & Grossman, LLC Encourages NeuroPace, Inc. (NPCE) Investors to Inquire about Securities Investigation

accessnewswire.com

Bronstein, Gewirtz & Grossman, LLC Encourages NeuroPace, Inc. (NPCE) Investors to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / November 20, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. ("NeuroPace" or "the Company") (NASDAQ:NPCE). Investors who purchased NeuroPace securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/cases/neuropace-inc-npce-investigation.

NeuroPace Investigation Details

On November 12, 2026, NeuroPace reported third-quarter revenue of $23.1 million, a decrease of 1.1% from the prior-year quarter, and lowered its full-year 2026 revenue guidance to $91 million to $92 million. The Company attributed the shortfall to a sales-force restructuring, disruptions at several large customer accounts, and the continuing effect of its exit from the SEEG distribution business. One quarter earlier, NeuroPace had raised its full-year revenue guidance to $99.5 million to $101.5 million and expressed confidence in the momentum of its core RNS business. Following this news, NeuroPace shares fell more than 37% on November 13, 2026.

What's Next for NeuroPace Investors?

If you are aware of any facts relating to this investigation or purchased NeuroPace securities, you can assist this investigation by visiting the firm's site: bgandg.com/cases/neuropace-inc-npce-investigation. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911

No Cost to NeuroPace Investors

We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for NeuroPace Securities Investigation?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE: Bronstein, Gewirtz & Grossman, LLC